LADENBURG THALMANN FINANCIAL SERVICES INC. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 129 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.9%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$4,000
-42.9%
1,043
-53.5%
0.00%
Q3 2019$7,000
-50.0%
2,2450.0%0.00%
Q2 2019$14,000
-58.8%
2,245
-63.9%
0.00%
Q1 2019$34,000
-17.1%
6,211
+2.7%
0.00%
Q4 2018$41,000
-39.7%
6,048
-5.0%
0.00%
-100.0%
Q3 2018$68,000
+19.3%
6,365
-3.9%
0.00%0.0%
Q2 2018$57,0000.0%6,6230.0%0.00%0.0%
Q1 2018$57,000
+5.6%
6,623
+21.2%
0.00%0.0%
Q4 2017$54,000
+315.4%
5,464
+419.4%
0.00%
Q3 2017$13,000
-72.3%
1,052
-63.5%
0.00%
-100.0%
Q2 2017$47,000
+213.3%
2,880
+172.7%
0.00%
Q1 2017$15,000
-21.1%
1,056
-22.1%
0.00%
Q4 2016$19,000
-20.8%
1,356
+0.2%
0.00%
Q3 2016$24,000
-11.1%
1,353
-29.2%
0.00%
Q2 2016$27,000
+17.4%
1,910
+0.7%
0.00%
Q1 2016$23,000
+27.8%
1,896
+36.8%
0.00%
Q4 2015$18,000
+63.6%
1,386
+38.6%
0.00%
Q3 2015$11,0001,0000.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$25,366,000100.00%
Artal Group S.A. 71,178,364$417,817,0007.38%
BVF INC/IL 8,394,000$49,273,0001.85%
Boothe Investment Group, Inc. 435,939$2,559,0001.49%
Campbell & CO Investment Adviser LLC 103,100$605,0000.37%
NEA Management Company, LLC 2,382,286$13,984,0000.31%
PINNACLE ASSOCIATES LTD 2,167,172$12,721,0000.24%
Eversept Partners, LP 410,593$2,410,1810.18%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$210,0000.12%
OCCUDO QUANTITATIVE STRATEGIES LP 66,299$389,0000.08%
View complete list of LEXICON PHARMACEUTICALS INC shareholders